KULMAP: Human Kidney, urinary tract and lung mapping center

KULMAP:人类肾脏、泌尿道和肺部绘图中心

基本信息

  • 批准号:
    9987373
  • 负责人:
  • 金额:
    $ 10万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-01 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT This Administrative Supplement application will add to the original aims of the UCSD HuBMAP KULMAP award, which are to: (1) Aim 1: Establish an experimental and computational pipeline for generating and analyzing 3D multi-omics maps for human tissues that will include single-nucleus RNA sequencing and chromatin accessibility mapping, highly multiplexed in situ imaging of RNA and proteins, and a computational framework to integrate different types of data to create coherent spatial maps of RNA, chromatin status and proteins; (2) Aim 2: Create a Lung Airways and Parenchymal Map (LAPMAP), covering the entire intrathoracic human airway; and (3) Aim 3: Create Bladder, Ureter and Kidney Maps (BUKMAP), covering human kidney and lower urinary tract. Our proposed supplemental work will improve the authorization/consent process by which the tissues are acquired for KULMAP, better inform the authorizing next of kin and provide clearer definitions and guides for investigator release of data, especially sequencing data, into the pipeline. In addition, testing variations in recovery protocols and comparing analysis results generated on the organs uniformly collected and shared between TMCs will clearly inform and optimize the quality and reliability of the data generated by KULMAP, and, importantly, contribute to the overall impact and success of HuBMAP. The Aims of the Supplement are ambitious but with the currently demonstrated support of the research recovery organizations, UCSD, and the several HuBMAP TMCs, they are feasible in the one-year award period with potential for long-term impact on human organ research. The Aims are to (1) develop a Donor Authorization Addendum acceptable to the HuBMAP Consortium and broadly to the Organ Procurement Organizations, that will directly address open-access genomic data sharing but that will ultimately broaden the diversity of donors available to the Consortium; (2) standardize and promote recovery of multiple, high quality organs and tissues appropriate for state-of-the-art molecular and cellular analyses and imaging to be applied in HuBMAP, to include testing of variations in recovery protocols on experimental quality; (3) promote sharing of single- donor, multiple organ recovery biospecimens among Tissue Mapping Centers, Transformative Technology Development Centers and Rapid Implementation of Technology Centers; and (4) promote ease and accuracy of donor health history metadata transfer to the HuBMAP database.
摘要 此行政补充申请将增加UCSD HuBMAP KULMAP的原始目标 奖项,其目的是:(1)目标1:建立一个实验和计算渠道,以产生和 分析人体组织的3D多组学图谱,包括单核RNA测序和 染色质可及性图谱,RNA和蛋白质的高度多重原位成像,以及计算 集成不同类型数据的框架,以创建RNA、染色质状态和 蛋白质;(2)目标2:创建覆盖整个胸腔的肺气道和实质地图(LAPMAP) 目标3:创建覆盖人体肾脏的膀胱、输尿管和肾脏地图(BUKMAP) 和下尿路。我们建议的补充工作将通过以下方式改进授权/同意流程 哪些组织是为KULMAP获得的,更好地通知授权的近亲,并提供更清楚的 调查员将数据,特别是测序数据发布到管道中的定义和指南。在……里面 此外,测试回收方案的变化并比较对器官产生的分析结果 统一收集并在TMC之间共享将清楚地告知和优化 KULMAP产生的数据,以及更重要的是,有助于HuBMAP的整体影响和成功。这个 补编的目标是雄心勃勃的,但目前已证明支持研究复苏 组织、UCSD和几个HuBMAP TMC,它们在一年的获奖期内是可行的,具有 可能对人体器官研究产生长期影响。其目的是(1)开发捐赠者授权 HuBMAP联合体和器官采购组织普遍可接受的增编, 这将直接解决开放获取的基因组数据共享问题,但这最终将扩大 向财团提供捐赠者;(2)标准化和促进多个高质量器官的回收 适合用于HuBMAP的最先进的分子和细胞分析和成像的组织, 包括对恢复方案中对实验质量的变化进行测试;(3)促进单一- 供体,组织映射中心间的多器官回收生物标本,变革性技术 开发中心和技术中心的快速实施;以及(4)促进易用性和准确性 将捐赠者的健康历史元数据传输到HuBMAP数据库。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James S. Hagood其他文献

Cooperative signaling between integrins and growth factor receptors in fibrosis
  • DOI:
    10.1007/s00109-020-02026-2
  • 发表时间:
    2021-01-03
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Horacio Maldonado;James S. Hagood
  • 通讯作者:
    James S. Hagood

James S. Hagood的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James S. Hagood', 18)}}的其他基金

KULMAP: Human Kidney, urinary tract and lung mapping center
KULMAP:人类肾脏、泌尿道和肺部绘图中心
  • 批准号:
    10413576
  • 财政年份:
    2018
  • 资助金额:
    $ 10万
  • 项目类别:
Organ Specific Project
器官特定项目
  • 批准号:
    10237125
  • 财政年份:
    2018
  • 资助金额:
    $ 10万
  • 项目类别:
KULMAP: Human Kidney, urinary tract and lung mapping center
KULMAP:人类肾脏、泌尿道和肺部绘图中心
  • 批准号:
    10237122
  • 财政年份:
    2018
  • 资助金额:
    $ 10万
  • 项目类别:
KULMAP: Human Kidney, urinary tract and lung mapping center
KULMAP:人类肾脏、泌尿道和肺部绘图中心
  • 批准号:
    9791201
  • 财政年份:
    2018
  • 资助金额:
    $ 10万
  • 项目类别:
Targeting the Apoptosis-Resistant Pulmonary Myofibroblast
靶向抗凋亡肺肌成纤维细胞
  • 批准号:
    8677065
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
Childhood Interstitial & Diffuse Lung Disease Scientific Conference
童年插页式
  • 批准号:
    8319294
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
Targeting the Apoptosis-Resistant Pulmonary Myofibroblast
靶向抗凋亡肺肌成纤维细胞
  • 批准号:
    8516090
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
Targeting the Apoptosis-Resistant Pulmonary Myofibroblast
靶向抗凋亡肺肌成纤维细胞
  • 批准号:
    8371194
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
Epigenetic Alterations in IPF Fibroblastic Foci
IPF 成纤维细胞灶的表观遗传改变
  • 批准号:
    7712750
  • 财政年份:
    2009
  • 资助金额:
    $ 10万
  • 项目类别:
Regulation of Fibroblast Phenotype in Lung Fibrosis
肺纤维化中成纤维细胞表型的调节
  • 批准号:
    7824718
  • 财政年份:
    2009
  • 资助金额:
    $ 10万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了